White House Announces “Path out of the Pandemic”

Today, President Biden announced a six-pronged national strategy to expand the federal government’s response to COVID-19. The Department of Labor is developing a rule that will require all employers with 100 or more employees to ensure their workers are fully vaccinated and require unvaccinated … Read more about White House Announces “Path out of the Pandemic”

The Debate: Masks in Schools

As summer draws to a close, fall brings unique challenges. The surge of COVID-19 cases, instigated by the Delta variant, has heavily impacted the beginning of the new school year. In July, the CDC recommended that all students and staff wear masks in schools, regardless of vaccination status. The … Read more about The Debate: Masks in Schools

Spectators barred from the Olympics due to COVID-19 risk

  Nestled amid a global pandemic, athletes from 206 countries are making their way to Japan to compete in the 2020 Tokyo Olympic Games.  Not the first Games to be affected by widespread health concerns: although the novel Zika virus was a concern during the 2016 Rio Olympics, the  World … Read more about Spectators barred from the Olympics due to COVID-19 risk

Reopening the Schools – Weighing the Risks

For nearly a year, schools in the United States have adapted to the pandemic by utilizing distance-learning models with varying success levels. Many studies indicate that the interruption to in-person learning has drastically affected standardized test scores, graduation rates, absenteeism, and … Read more about Reopening the Schools – Weighing the Risks

COVID-19 ONE YEAR LATER, Part II: Testing and Vaccines

In the second part of VIGILINT's two-part series COVID-19 1 Year Later, VIGILINT Ops Analyst and blogger Colin Schilly dives into the two critical hallmarks of the pandemic. Testing and vaccines. The development and rollout of several effective vaccines in under a year offer great hope for the … Read more about COVID-19 ONE YEAR LATER, Part II: Testing and Vaccines

COVID-19 ONE YEAR LATER, Part I: The Best and Worst Handlings of the COVID-19 Crisis

On January 10, 2020, VIGILINT first reported a new strain of a coronavirus connected to a cluster of pneumonia cases linked to Wuhan, China. No one could have predicted the year that would follow. As of publishing, worldwide cases have reached 104 million with 2.27 million deaths. VIGILINT … Read more about COVID-19 ONE YEAR LATER, Part I: The Best and Worst Handlings of the COVID-19 Crisis

COVID-19 Transmission: Surfaces

There is some risk of COVID-19 transmission from surfaces, but the primary disease transfer mode is airborne transmission. Several studies have analyzed the detection of COVID-19 on various surfaces. One such study, published by the New England Journal of Medicine in March 2020, largely shaped the … Read more about COVID-19 Transmission: Surfaces

COVID-19 Update: Vaccine Distribution

The Trump administration is reversing its COVID-19 vaccination strategy by authorizing the release of Pfizer-BioNtech and Moderna's federally stockpiled vaccines. The previous policy withheld half the purchased doses to ensure the supply necessary for second doses, and states could only receive … Read more about COVID-19 Update: Vaccine Distribution

COVID-19 Update: On the Single Deadliest Day of the Pandemic – LA County is Hardest Hit

The Situation in Los Angeles Yesterday was the single deadliest day of the pandemic with 4,000 deaths, and nowhere is harder hit than Los Angeles County. Cases have spiked drastically since December, with 809,052 cases and 10,739 deaths. Deaths were occurring every 8 minutes yesterday.  The … Read more about COVID-19 Update: On the Single Deadliest Day of the Pandemic – LA County is Hardest Hit

COVID-19 Vaccines: What are the Side Effects?

The World Health Organization (WHO) became aware of the disease known as COVID-19 on December 31, 2019. Since then, there have been 86 million confirmed cases, over 1.8 million deaths, and 355,000 deaths in the U.S. alone. After months of effort and billions of dollars spent, distribution of the … Read more about COVID-19 Vaccines: What are the Side Effects?